Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

por Howard, Campbell, Noe, Adele, Skerjanec, Andrej, Holzhauer, Björn, Wernsing, Margaret, Ligueros-Saylan, Monica, Thuren, Tom
Publicado 2014

Rationale and design of TRANSITION: a randomized trial of pre‐discharge vs. post‐discharge initiation of sacubitril/valsartan

por Pascual‐Figal, Domingo, Wachter, Rolf, Senni, Michele, Belohlavek, Jan, Noè, Adele, Carr, David, Butylin, Dmytro
Publicado 2017

Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure

por Witte, Klaus K., Wachter, Rolf, Senni, Michele, Belohlavek, Jan, Straburzynska‐Migaj, Ewa, Fonseca, Candida, Lonn, Eva, Noè, Adele, Schwende, Heike, Butylin, Dmytro, Chiang, YannTong, Pascual‐Figal, Domingo
Publicado 2022

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry

por Filippatos, Gerasimos, Khan, Sadiya Sana, Ambrosy, Andrew P., Cleland, John G.F., Collins, Sean P., Lam, Carolyn S.P., Angermann, Christiane E., Ertl, Georg, Dahlström, Ulf, Hu, Dayi, Dickstein, Kenneth, Perrone, Sergio V., Ghadanfar, Mathieu, Bermann, Georgina, Noe, Adele, Schweizer, Anja, Maier, Thomas, Gheorghiade, Mihai
Publicado 2015